T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Kymera Therapeutics
KYMR
$9.51B
| $89.5M | 0.01% |
1,844,926
+911,948
| +98% | +$39.6M |
|
827
Brink's
BCO
$4.72B
| $89.3M | 0.01% |
1,162,790
-162,151
| -12% | -$12.6M |
|
828
CarMax
KMX
$8.52B
| $89.3M | 0.01% |
691,761
-190,611
| -22% | -$23.6M |
|
829
PTC Therapeutics
PTCT
$6.01B
| $89.3M | 0.01% |
2,112,668
-44,206
| -2% | -$1.89M |
|
|
SAGE
830
DELISTED
Sage Therapeutics
SAGE
| $89.3M | 0.01% |
1,571,553
-835,294
| -35% | -$59M |
|
831
Cinemark Holdings
CNK
$4.37B
| $89.1M | 0.01% |
4,060,137
-120,395
| -3% | -$2.67M |
|
832
Federal Signal
FSS
$7.51B
| $89M | 0.01% |
2,212,166
+690,725
| +45% | +$28.4M |
|
833
Nucor
NUE
$61.8B
| $88.9M | 0.01% |
926,770
-91,398
| -9% | -$8.55M |
|
834
Exponent
EXPO
$3.24B
| $88.7M | 0.01% |
993,836
-11,277
| -1% | -$1.06M |
|
835
Flowserve
FLS
$10.3B
| $88.5M | 0.01% |
2,194,366
+132,124
| +6% | +$5.46M |
|
836
Gartner
IT
$11.6B
| $88.3M | 0.01% |
364,651
+2,903
| +0.8% | +$635K |
|
837
1stdibs.com
DIBS
$163M
| $88M | 0.01% |
+2,660,801
| New | +$68.5M |
|
|
PMT
838
PennyMac Mortgage Investment
PMT
$828M
| $87.9M | 0.01% |
4,175,874
-858
| -0% | -$17.1K |
|
839
Tidewater
TDW
$4.55B
| $87.9M | 0.01% |
7,290,714
+185,755
| +3% | +$2.47M |
|
840
Heritage Financial
HFWA
$1.23B
| $87.6M | 0.01% |
3,499,970
-21,275
| -0.6% | -$593K |
|
|
TWTR
841
DELISTED
Twitter, Inc.
TWTR
| $87.2M | 0.01% |
1,267,646
-10,975
| -0.9% | -$673K |
|
842
Brunswick
BC
$5.29B
| $86M | 0.01% |
863,612
+22,717
| +3% | +$2.31M |
|
843
RBC Bearings
RBC
$17.5B
| $85.4M | 0.01% |
428,472
-15,846
| -4% | -$3.13M |
|
|
CERE
844
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $85.2M | 0.01% |
3,327,411
-72,477
| -2% | -$1.04M |
|
|
HZNP
845
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $85.2M | 0.01% |
909,466
-167,237
| -16% | -$15.4M |
|
846
SL Green Realty
SLG
$4.08B
| $84.6M | 0.01% |
1,057,470
-1,536,049
| -59% | -$117M |
|
847
Quanterix
QTRX
$135M
| $84.5M | 0.01% |
1,440,259
-662,795
| -32% | -$38.5M |
|
|
NUVA
848
DELISTED
NuVasive, Inc.
NUVA
| $84.2M | 0.01% |
1,241,575
-207,643
| -14% | -$14.2M |
|
|
NVTA
849
DELISTED
Invitae Corporation
NVTA
| $84.1M | 0.01% |
2,493,365
-38,411
| -2% | -$1.25M |
|
|
IBTX
850
DELISTED
Independent Bank Group, Inc.
IBTX
| $84M | 0.01% |
1,135,071
-4,201
| -0.4% | -$318K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.